HKTDC Chairman in the UK to promote new opportunities through Hong Kong
HONG KONG, Oct 27, 2022 – (ACN Newswire) – With many UK businesses looking for…
HONG KONG, Oct 27, 2022 – (ACN Newswire) – With many UK businesses looking for…
SINGAPORE, Oct 27, 2022 – (ACN Newswire) – Thoughtful Media Group Inc (“Thoughtful Media Group”…
Congratulates Mirum on Positive Topline Phase 3 Data in progressive familial intrahepatic cholestasis (PFIC) CANbridge…
– Yun Han named Chief Accounting Officer and Interim Chief Financial Officer – – Initial…
DALLAS, Oct. 26, 2022 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (“Taysha”), a…
Utilizing decades of experience, Paschal will bring his strategic leadership and technical know-how to Growcentia…
Ottawa, Ontario–(Newsfile Corp. – October 26, 2022) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST”…
Early adoption of the correct media management is crucial for laying the foundations for the…
SINGAPORE & NEW YORK–(BUSINESS WIRE)–SWIFT and MonetaGo have achieved an important milestone in the global…
SAN DIEGO–(BUSINESS WIRE)–FutureProof Technologies has announced two key hires to support the launch of a…
GAINESVILLE, Fla. and CAMBRIDGE, Mass. and LONDON, Oct. 26, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies…
GAINESVILLE, Fla. and CAMBRIDGE, Mass. and LONDON, Oct. 26, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies…
Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines…
Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines…
REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech…
REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech…
Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million…
Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million…
ROCKVILLE, MD, Oct. 26, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
ROCKVILLE, MD, Oct. 26, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…